Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Takeda Clinches Key US Clearance for Shire Takeover
July 10, 2018
- Nichi-Iko Ties Up with Sunward for Malaysia, Singapore Biz
July 10, 2018
- No Major Damage for Drug Makers, Wholesaler Logistics: West Japan Downpours
July 10, 2018
- Ethical Drug Sales Up 2.6% in May: Crecon
July 9, 2018
- Eisai/Biogen Say Alzheimer’s Candidate BAN2401 Delivered Positive Data at 18 Month Analysis
July 9, 2018
- New Takeda Global Headquarters Designed for LGBT Inclusion
July 9, 2018
- Shionogi Regains Exclusive US Rights to Symproic, Seeking New Partner
July 9, 2018
- No Drug Breaks 100 Billion Yen Mark in FY2017 Japan Sales Ranking: Jiho Tally
July 6, 2018
- Use of Digital Health Apps Could Reduce Medical Expenditure by 339 Billion Yen Annually: IQVIA
July 6, 2018
- Sumitomo Dainippon Files Thiotepa for Conditioning Regimen Prior to Autologous HSCT in Pediatric Solid Tumors
July 5, 2018
- Pfizer Wringing Hands over PMP Eligibility for Lorlatinib; It Might Earn 1st Conditional OK, but It’s “4th” ALK Inhibitor
July 5, 2018
- Meiji Holdings Makes Kaketsuken’s Successor Company Its Consolidated Subsidiary
July 4, 2018
- Single-Dose Flu Drug Xofluza Filed in Taiwan: Shionogi
July 3, 2018
- Takeda Celebrates Grand Opening for New Global Headquarters
July 3, 2018
- JCR Launches PIII Study of Growject for SHOX Deficiency
July 3, 2018
- Sawai President Shows Eagerness to “Take Over” To-Be-Withdrawn LLPs
July 2, 2018
- With Focus on CGRP, Development of New Generation of Preventive Treatments for Migraines Heating Up
July 2, 2018
- Baxalta Appeals to IP High Court in Hemlibra Patent Lawsuit against Chugai
July 2, 2018
- Weber Earns 1.2 Billion Yen in FY2017, Logging Western-Level Pay Ratio
June 29, 2018
- Grilled by Shareholders, Takeda CEO Seeks Understanding for Shire Deal
June 29, 2018
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…